LOADING

Type to search

BioCryst Pharma Appoints Anthony Doyle Chief Financial Officer

BioTech

BioCryst Pharma Appoints Anthony Doyle Chief Financial Officer

Share
biocryst-pharma-appoints-anthony-doyle-chief-financial-officer

Xconomy
Raleigh-Durham
— 

Anthony Doyle has been named chief financial officer of BioCryst Pharmaceuticals (NASDAQ: BCRX). He is joining the Durham, NC, rare disease drug developer from Worldwide Clinical Trials, where he has been CFO since 2014. His experience also includes several roles at General Electric (NYSE: GE). BioCryst is awaiting an FDA decision for berotralstat, a treatment for hereditary angioedema.

Tags:

You Might also Like

Leave a Comment

Your email address will not be published. Required fields are marked *